Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
A Systematic Review of Combination and High-Dose Atypical Antipsychotic Therapy in Patients with Schizophrenia [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2011 Dec. (CADTH Optimal Use Report, No. 1.1B.)
A Systematic Review of Combination and High-Dose Atypical Antipsychotic Therapy in Patients with Schizophrenia [Internet].
Show details1. CLZ Combination Therapy versus CLZ Monotherapy (Figures A1.1 – A1.41)
Figure A1.13. Forest plot for CLZ comb versus CLZ mono: Response rate (RR (95% CI)) — reference case
Figure A1.23. Forest plot for CLZ comb versus CLZ mono: Akathisia (RR (95% CI)) — reference case
Figure A1.24. Forest plot for CLZ comb versus CLZ mono: Akathisia (RR (95% CI)) — subgroup by drug
Figure A1.27. Forest plot for CLZ comb versus CLZ mono: Parkinsonism (RR (95% CI)) — reference case
3. Forest Plot for High-Dose Non-CLZ AAP versus Standard-Dose CLZ Monotherapy (Figures A3.1 – A3.35)
4. High-Dose Non-CLZ AAP versus Standard-Dose Non-CLZ APD (Figures A4.1 – A4.19)
Figure A4.7. High dose non-CLZ AAP versus non-CLZ APD: Response rate (RR (95% CI)) — reference case
- CLZ Combination Therapy versus CLZ Monotherapy (Figures A1.1 – A1.41)
- Forest Plot for Non-CLZ Combinations versus Non-CLZ Monotherapy (Figures A2.1 – A2.3)
- Forest Plot for High-Dose Non-CLZ AAP versus Standard-Dose CLZ Monotherapy (Figures A3.1 – A3.35)
- High-Dose Non-CLZ AAP versus Standard-Dose Non-CLZ APD (Figures A4.1 – A4.19)
- FOREST PLOTS FROM RANDOM EFFECTS META-ANALYSIS (REFERENCE CASE ANALYSES AND SUBG...FOREST PLOTS FROM RANDOM EFFECTS META-ANALYSIS (REFERENCE CASE ANALYSES AND SUBGROUPS BY DRUG) - A Systematic Review of Combination and High-Dose Atypical Antipsychotic Therapy in Patients with Schizophrenia
Your browsing activity is empty.
Activity recording is turned off.
See more...